Terbufibrol

Synonyms: 特丁贝罗
Terbufibrol 是一种具有口服活性的降血脂剂,可抑制肝脏 Cholesterol 7 alpha-hydroxylase,并阻断肝脏胆固醇合成过程中 Acetate 与 HMG-CoA 之间的某个步骤,从而降低血清总胆固醇、HDL、LDL、脂蛋白水平以及胆固醇/磷脂比值,且脂蛋白组分的变化具有剂量和性别依赖性,在狒狒和大鼠体内具有持续的降胆固醇活性,可用于高胆固醇血症的相关研究。
产品编号: MS-A51520 纯度: 98.39% CAS No.: 56488-59-6 分子式: C20H24O5 分子量: 344.40
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
3-5 天
25mg
询价
3-5 天
50mg
询价
询价
100mg
询价
询价
200mg
询价
询价
500mg
询价
询价
1g
询价
询价

产品描述

Terbufibrol 是一种具有口服活性的降血脂剂,可抑制肝脏 Cholesterol 7 alpha-hydroxylase,并阻断肝脏胆固醇合成过程中 Acetate 与 HMG-CoA 之间的某个步骤,从而降低血清总胆固醇、HDL、LDL、脂蛋白水平以及胆固醇/磷脂比值,且脂蛋白组分的变化具有剂量和性别依赖性,在狒狒和大鼠体内具有持续的降胆固醇活性,可用于高胆固醇血症的相关研究。

生物实验数据

生物活性 Terbufibrol is an orally active hypolipidemic agent that inhibits hepatic Cholesterol 7 alpha-hydroxylase and blocks a step between Acetate and HMG-CoA in hepatic cholesterol synthesis, thereby reducing serum total cholesterol, HDL, LDL, lipoprotein levels, and the cholesterol/phospholipid ratio, with changes in lipoprotein fractions being dose- and sex-dependent; it exhibits sustained cholesterol-lowering activity in baboons and rats and can be used for research related to hypercholesterolemia.
IC50 & Target

Cholesterol 7 alpha-hydroxylase

 

体内研究
(In Vivo)

Terbufibrol (每日口服,12-200 mg/kg/day,持续 8 周) 可剂量依赖性地降低正常狒狒的血清总胆固醇水平,并调节脂蛋白的含量与组成;在 200 mg/kg/day 剂量下给 8 周后,血清 TC 水平降低 69.1%。
Terbufibrol (20-200 mg/kg/天;口服;每日;持续 4 周) 可剂量依赖性降低高脂饲料 (HPF) 诱导的内源性高胆固醇血症雄性狒狒的血清总胆固醇水平,并调节脂蛋白胆固醇水平;在该饮食模型中,200 mg/kg/天剂量下血清总胆固醇 (TC) 最大降低幅度达 80%,其 ED50 为 60 mg/kg/天。

Animal Model: Papio cynocephalus (2-3 years old, 4-7 kg, equal numbers of males and females)
Dosage: 12 mg/kg/day; 50 mg/kg/day; 200 mg/kg/day
Administration: p.o.; daily; 8 weeks
Result: Reduced serum total cholesterol by 6.7% after 8 weeks at 12 mg/kg/day.
Decreased VLDL by a mean of 20% and HDL by a mean of 21% respectively at 12 mg/kg/day.
Increased LDL in males by 36% at 12 mg/kg/day.
Reduced serum total cholesterol by 21.1% after 8 weeks at 50 mg/kg/day.
Decreased VLDL by a mean of 12% and HDL by a mean of 43% at 50 mg/kg/day.
Decreased LDL in males by 35% at 50 mg/kg/day.
Reduced serum total cholesterol by 69.1% after 8 weeks at 200 mg/kg/day.
Reduced total lipoprotein by a mean of 52% across sexes at 200 mg/kg/day.
Decreased LDL by a mean of 46% and HDL by a mean of 57% at 200 mg/kg/day.
Reduced LDL-TC and HDL-TC, with a greater effect on LDL-TC, increasing the HDL-TC/LDL-TC ratio by 56% compared to control at 200 mg/kg/day.
Caused a dose-related decrease in the TC/PL ratio in VLDL due to increased PL content.
Caused a dose-related decrease in the TC/PL ratio in LDL due to reduced TC content and increased TG content.
Caused a trend of decreased PL with increasing dose in HDL.
Animal Model: Papio cynocephalus (2-3 years old, 4-7 kg, male only)
Dosage: 20 mg/kg/day; 60 mg/kg/day; 200 mg/kg/day
Administration: p.o.; daily; 4 weeks
Result: Primarily decreased HDL-TC, reducing the HDL-TC/LDL-TC ratio by 17% at 20 mg/kg/day.
Decreased LDL-TC more than HDL-TC, increasing the HDL-TC/LDL-TC ratio from a control value of 1.8 to 4.4 (a 144% increase) at 60 mg/kg/day.
Produced a maximum 80% reduction in serum TC at 200 mg/kg/day.
Decreased LDL-TC more than HDL-TC, and also reduced HDL, HDL-TC, LDL, and LDL-TC/PL at 200 mg/kg/day.
Was approximately 10 times more active than clofibrate at reducing serum TC in this model.
Had an ED50 for serum TC reduction of 60 mg/kg/day for the HPF-diet.
性状 固体
颜色 White to off-white

化学信息

分子量 344.40
分子式 C20H24O5
CAS No. 56488-59-6
别名 特丁贝罗

储存&溶解度

体内实验配方
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.9 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 200 mg/mL (580.72 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM2.9036 mL14.5180 mL29.0360 mL72.5900 mL
5 mM0.5807 mL2.9036 mL5.8072 mL14.5180 mL
10 mM0.2904 mL1.4518 mL2.9036 mL7.2590 mL
15 mM0.1936 mL0.9679 mL1.9357 mL4.8393 mL
20 mM0.1452 mL0.7259 mL1.4518 mL3.6295 mL
25 mM0.1161 mL0.5807 mL1.1614 mL2.9036 mL
30 mM0.0968 mL0.4839 mL0.9679 mL2.4197 mL
40 mM0.0726 mL0.3630 mL0.7259 mL1.8148 mL
50 mM0.0581 mL0.2904 mL0.5807 mL1.4518 mL
60 mM0.0484 mL0.2420 mL0.4839 mL1.2098 mL
80 mM0.0363 mL0.1815 mL0.3630 mL0.9074 mL
100 mM0.0290 mL0.1452 mL0.2904 mL0.7259 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础